iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials episode artwork

EPISODE · Jun 7, 2023 · 12 MIN

iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials

from VJHemOnc Podcast · host VJHemOnc

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more. In this podcast, you will hear from John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, Joseph Melenhorst, PhD, Cleveland Clinic, Cleveland, OH, and Tanya Siddiqi, MD, City of Hope, Duarte, CA, who discuss challenges with implementing CAR-T therapy in CLL, ongoing clinical trials, and research exploring combination approaches with CAR-T cells and Bruton's tyrosine kinase (BTK) inhibitors.

Episode metadata supplied by the publisher feed · Published Jun 7, 2023

Embed this episode

NOW PLAYING

iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials

0:00 12:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VJHemOnc Podcast?

This episode is 12 minutes long.

When was this VJHemOnc Podcast episode published?

This episode was published on June 7, 2023.

Can I download this VJHemOnc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!